COBRE: UNE MED CTR: CORE C: HISTOLOGY CORE
COBRE: UNE MED CTR: CORE C: HISTOLOGY CORE
批准号:
8360392
负责人:
Kay-Uwe Wagner
金额:
$8.87万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-06-30
关键词:
AntibodiesAreaCenters of Research ExcellenceCore FacilityDataDevelopmentEquipmentExtramural ActivitiesFundingGenerationsGrantHistologyHuman ResourcesIndividualLaboratoriesMentorsMethodologyMissionMolecular BiologyNational Center for Research ResourcesNebraskaPhenotypePrincipal InvestigatorProceduresReagentRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResourcesServicesSourceStandardizationSystemTechnical ExpertiseTimeTrainingUnited States National Institutes of Healthcostexperienceimprovedinformation frameworkneurosurgeryprogramsquality assurancesuccessweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The Histology Core has the mission to serve the investigators of the COBRE Program with their needs in specialized morphological and histological analysis of neurosensory development and relevant mousephenotypes. A Core Facility for histology offers several advantages to the COBRE investigators and the
COBRE Program: 1) Enrichment of Resources: The establishment of the Core Facility with expert personnel will provide the individual investigators with a multitude of services, equipment resources and technical expertise that is not readily available within their individual laboratories. This will significantly broaden the depth of the individual research projects and support the development of state-of-the-art and technologically
comprehensive research programs within the individual junior investigators' laboratories. 2) Efficiency of Personnel and Cost Management: The concentration of such resources within the Core allows for better efficiency and standardization in the usage of typically costly reagents, such as for example, specialized
antibodies. Furthermore, the involvement of the highly trained and experienced Director of Phenotyping Services at UNMC, Ms. M. Anita Jennings, will reduce the need for each PI to allocate their personnel to methodologies that require extensive training and time in order to be proficiently carried out. In addition, the
use of common reagents will better allow investigators from the different laboratories to compare and interpret results. 3) Quality Assurance, Mentoring and Information Flow: Scientifically, the Core will enable a standardization of procedures, of flow of information, and of frameworks for interpretation that will greatly
enhance the infrastructure for success of individual projects through common quality assurance, data generation and interpretation standards. In this way, investigators benefit from the combined expertise generated through all of the projects. Most importantly, information flow will be improved through the use of a common Website for access to the Histology Core that integrates the efforts of individual investigators along
common themes. 4) Enhancement of Infrastructure: The long-term objective of the COBRE, namely, to establish a critical mass of investigators on one area through the Center for Neurosensory Development in Nebraska, will also be served by the Core Facility. The availability of a specialized Histology Core Facility will increase the competitiveness of COBRE investigators for extramural funding, serve in retention of funded investigators, and attract and recruit new investigators into the Center for Neurosensory Development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the PTAP domain of TSG101 in ERBB2-associated mammary cancer
-
批准号:9377349
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2017
-
负责人:Kay-Uwe Wagner
-
依托单位:
Temporally controlled oncogene expression in a novel pancreatic cancer model
-
批准号:8337326
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2011
-
负责人:Kay-Uwe Wagner
-
依托单位:
Temporally controlled oncogene expression in a novel pancreatic cancer model
-
批准号:8191738
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2011
-
负责人:Kay-Uwe Wagner
-
依托单位:
COBRE: UNE MED CTR: CORE B: MOUSE GENOME ENGINEERING
-
批准号:8168356
-
项目类别:
-
资助金额:$6.46万
-
财政年份:2010
-
负责人:Kay-Uwe Wagner
-
依托单位:
COBRE: UNE MED CTR: CORE C: HISTOLOGY CORE
-
批准号:8168357
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2010
-
负责人:Kay-Uwe Wagner
-
依托单位:
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer
-
批准号:7934238
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2009
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:8234382
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:9029286
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:8633003
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:8825336
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:7544448
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:7750611
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:7014241
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:7175474
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:7338333
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Growth-Regulatory Signaling Networks in Breast Cancer
-
批准号:8464651
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2006
-
负责人:Kay-Uwe Wagner
-
依托单位:
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer
-
批准号:8212492
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2002
-
负责人:Kay-Uwe Wagner
-
依托单位:
Tumor Susceptibility Gene 101 Deficiency and Neoplasia
-
批准号:6936413
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2002
-
负责人:Kay-Uwe Wagner
-
依托单位:
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer
-
批准号:7754689
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2002
-
负责人:Kay-Uwe Wagner
-
依托单位:
Tsg101 - a Modulator of ErbB2 Signaling in Breast Cancer
-
批准号:7583856
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2002
-
负责人:Kay-Uwe Wagner
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: